Besifloxacin HCl

Catalog No.S3055

For research use only.

Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic.

Besifloxacin HCl  Chemical Structure

CAS No. 405165-61-9

Purity & Quality Control

Choose Selective Antibiotics Inhibitors

Biological Activity

Description Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic.
In vitro

Besifloxacin is a novel 8-chloro-fluoroquinolone agent with potent, bactericidal activity against prevalent and drug-resistant pathogens.besifloxacin is the most potent agent tested against gram-positive pathogens and anaerobes and is generally equivalent to comparator fluoroquinolones in activity against most gram-negative pathogens. Besifloxacin demonstrates potent, broad-spectrum activity, which is particularly notable against gram-positive and gram-negative isolates that are resistant to other fluoroquinolones and classes of antibacterial agents.

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 430.3
Formula

C19H21ClFN3O3.HCl

CAS No. 405165-61-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT00905762 Completed Drug: Gatifloxacin|Drug: Moxifloxacin|Drug: Besifloxacin Healthy Bausch & Lomb Incorporated March 2009 Phase 1

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Besifloxacin HCl | Besifloxacin HCl ic50 | Besifloxacin HCl price | Besifloxacin HCl cost | Besifloxacin HCl solubility dmso | Besifloxacin HCl purchase | Besifloxacin HCl manufacturer | Besifloxacin HCl research buy | Besifloxacin HCl order | Besifloxacin HCl mouse | Besifloxacin HCl chemical structure | Besifloxacin HCl mw | Besifloxacin HCl molecular weight | Besifloxacin HCl datasheet | Besifloxacin HCl supplier | Besifloxacin HCl in vitro | Besifloxacin HCl cell line | Besifloxacin HCl concentration | Besifloxacin HCl nmr